Literature DB >> 10939802

Cytomegalovirus infection and disease after autologous CD34-selected peripheral blood stem cell transplantation for multiple myeloma: no evidence of increased incidence based on polymerase-chain-reaction monitoring.

K S Peggs, S J Ings, P D Kottaridis, K Yong, C D Williams, A H Goldstone, S Mackinon.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10939802

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  2 in total

1.  Hemopoietic recovery and infectious complications in breast cancer and multiple myeloma after autologous CD34+ cell-selected peripheral blood progenitor cell transplantation.

Authors:  Luca De Rosa; Gabriel Anghel; Annino Pandolfi; Massimo Riccardi; Rachele Amodeo; Ignazio Majolino
Journal:  Int J Hematol       Date:  2004-01       Impact factor: 2.490

2.  High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells.

Authors:  A K Blystad; H Holte; S Kvaløy; E Smeland; J Delabie; G Kvalheim
Journal:  Bone Marrow Transplant       Date:  2001-11       Impact factor: 5.483
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.